ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
9.00
0.00
( 0.00% )
Updated: 20:00:00

E-therapeutics Plc Financial Summary

The current ETX market cap is 52.55M. The company's latest EPS is GBP -0.0191 and P/E is -4.71.

Year End January 30 2024 20202021202220232024
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 456k317k477k475k318k
Operating Income -2.89M-4.49M-9.57M-10.24M-13.79M
Net Income -2.35M-3.68M-8.07M-8.27M-11.17M
Year End January 30 2024 20202021202220232024
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Assets 4.79M14.31M29.76M34.64M24.97M
Total Liabilities 284k427k1.79M1.6M2.98M
Total Equity 4.5M13.88M27.97M33.04M21.99M

Cash Flow

Year End January 30 2024 20202021202220232024
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Operating -2.03M-3.36M-7.8M-8.01M-10.9M
Investing -1,000-5.07M-9.94M15.31M232k
Financing -35k12.6M22.33M13.05M-359k
Market Cap 52.55M
Price to Earnings Ratio -4.71
Price to Sales Ratio 180
Price to Cash Ratio 2.54
Price to Book Ratio 2.39
Dividend Yield -

Share Statistics

Shares Outstanding 583.84M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -30.77%
52 Week High 13.00
52 Week Low 8.80
Spread (Intraday) 0.5 (5.26%)

Company Info

Company Name E-therapeutics Plc
Address 4 kingdom street
london
Website https://www.etherapeutics.co.uk
Industry coml physical, biologcl resh (8731)